Correlation Between Emergent Biosolutions and XORTX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and XORTX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and XORTX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and XORTX Therapeutics, you can compare the effects of market volatilities on Emergent Biosolutions and XORTX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of XORTX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and XORTX Therapeutics.
Diversification Opportunities for Emergent Biosolutions and XORTX Therapeutics
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Emergent and XORTX is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and XORTX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XORTX Therapeutics and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with XORTX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XORTX Therapeutics has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and XORTX Therapeutics go up and down completely randomly.
Pair Corralation between Emergent Biosolutions and XORTX Therapeutics
Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 0.67 times more return on investment than XORTX Therapeutics. However, Emergent Biosolutions is 1.49 times less risky than XORTX Therapeutics. It trades about 0.1 of its potential returns per unit of risk. XORTX Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 556.00 in Emergent Biosolutions on September 2, 2024 and sell it today you would earn a total of 456.00 from holding Emergent Biosolutions or generate 82.01% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Emergent Biosolutions vs. XORTX Therapeutics
Performance |
| Timeline |
| Emergent Biosolutions |
| XORTX Therapeutics |
Emergent Biosolutions and XORTX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Emergent Biosolutions and XORTX Therapeutics
The main advantage of trading using opposite Emergent Biosolutions and XORTX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, XORTX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XORTX Therapeutics will offset losses from the drop in XORTX Therapeutics' long position.| Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
| XORTX Therapeutics vs. Context Therapeutics | XORTX Therapeutics vs. Neurosense Therapeutics | XORTX Therapeutics vs. Quoin Pharmaceuticals Ltd | XORTX Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets |